R & BBiotech was founded with the aim to develop and integrate novel technologies, products and services to support and optimize the process of developing innovative diagnostics and therapeutics that are currently being envisioned and realized via talented reserchers at universities, institutions and industries within the fields of biotechnology, nanotechnology and pharmaceutical R & D.
R & B Biotech is
currently setting up an R & D Project Development and Technology Transfer
Fund in addition to working in close collaboration with the Department of
Product Development at the University of Applied Sciences in Bielefeld,
Germany. This enables us to establish and support strong collaborative product
development, integration and application initiatives with other universities,
institutions and companies.
We believe and are
exhibiting that this working structure of combining groups with diverse
expertise and resources will provide a solid structure to enable significant
technology advancements within the Biotech Industry to assist in the
development of valuable diagnostic applications and therapies.
With
many product development and integration projects with key partners underway
since mid-2004, R & B Biotech introduced its first
series of services in 2007. These are:
CMO for Bioprocess R & D and Production cGMP
Contract Manufacturing approved for production up to phase 3 clinical trials of
monoclonal antibodies and recombinant proteins in suspension or microcarrier
mammalian cell cultures.
